This series will focus on basic, translational and clinical research related to the field of tumor microenvironment and immunotherapy. All article types are welcome in this article collection. The series is guest edited by Professors Bo Zhu, Qian Chu, and Shengxiang Ren.
Call for papers: Tumor microenvironment and immunotherapy
Aims and scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Delong Liu, New York Medical College
Kongming Wu, Tongji Medical College
Editor's quote (Dr. Delong Liu)
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
Springer Nature Oncology Portfolio
Discover the range of academic oncology titles at Springer Nature here.
Annual Journal Metrics
6 days to first decision for all manuscripts (Median)
27 days to first decision for reviewed manuscripts only (Median)
399,525 Downloads (2021)
443 Altmetric mentions (2021)
On the blog
03 February 2022